Bio Spec Overview
Ignite Creation Date:
2025-12-26 @ 10:18 PM
Last Modification Date:
2025-12-26 @ 10:18 PM
Retention:
SAMPLES_WITH_DNA
Description:
Laboratory Blood Test
For the development of the new biomarkers using the technique of Mass-spectometry, a blood sample of maximal 10 ml blood will be taken via using a dry blood spot filter card. To proof the correct MPS1 diagnosis in those patients where up to the enrolment in the study no genetic testing has been done, sequencing of MPS1 will be done. The analyses will be done at the Centogene AG Am Strande 7 18055 Rostock Germany
For the development of the new biomarkers using the technique of Mass-spectometry, a blood sample of maximal 10 ml blood will be taken via using a dry blood spot filter card. To proof the correct MPS1 diagnosis in those patients where up to the enrolment in the study no genetic testing has been done, sequencing of MPS1 will be done. The analyses will be done at the Centogene AG Am Strande 7 18055 Rostock Germany
Section:
Laboratory Blood Test
For the development of the new biomarkers using the technique of Mass-spectometry, a blood sample of maximal 10 ml blood will be taken via using a dry blood spot filter card. To proof the correct MPS1 diagnosis in those patients where up to the enrolment in the study no genetic testing has been done, sequencing of MPS1 will be done. The analyses will be done at the Centogene AG Am Strande 7 18055 Rostock Germany